That list did reasonably well in 2024 (+29%), as did the S&P (+25%), and happily so did the portfolio (+30%). The portfolio’s gains were even higher in the summer months, when a couple of what might be referred to (perhaps generously) as ‘special situations’ seemed to be working out, and by which point my largest holding (Plus500) had gained over 60%. By the end of August the portfolio was up 48% and it all felt like things were going well… which is often when things start to go not so well.
In this case the two ‘special situations’ started to become even more special, and not in the way that investors like. They weren’t especially large positions (albeit that is in the context of a portfolio that rarely exceeds eight positions). As at the year-end they are now reasonably large positions, at 18% for Vistry and 13% for Close Brothers.
Vistry is a stock I have owned on and off for a while now. In essence it is becoming the story of a charismatic CEO out to prove a business model that can deliver more homes, to more people, at a better price, faster, and with much higher returns on capital for shareholders, than the classic homebuilder business model.
To say the ‘jury is out’ would be to put it politely – the stock is in the doghouse after a blundered first year of execution, dropped mid-term targets and three consecutive profit warnings. With 2024 potentially helping to catalyse change in the group and with the CEO and his long-term backers still involved, there is a lot to do to prove the strategy out. However, should returns rise to above 20% in the next few years, the price to book of 0.55x at present is likely to have been a great entry level.
Close Brothers presents something of a binary outcome, with the judgement of the Supreme Court – no less – likely to strongly influence sentiment and future profits when it returns verdicts on three test cases in the spring. Not being a lawyer, this idea started on the (admittedly perhaps too simple) premise that a potential loss of ~£100m didn’t really fit with a market cap fall of ~£750m. By August this was looking like a good bet, with the shares around 80% above the price I had paid for them, but then in October the potential ~£100m loss looked more like ~£300m and the shares slumped back to new lows.
Of the eight current stocks in the portfolio, four are UK listed and four are US listed. The UK stocks held trade on an average of 6x earnings, whilst the US stocks held trade on an average of 26x. This reflects a broad dichotomy across the two markets. It is hard to find inexpensive stocks in the US, but easy to find high quality listed businesses. Meanwhile, it is easy to find inexpensive stocks in the UK, but hard to find high quality listed businesses. 2024 certainly taught the (admittedly rather enduring) lesson that owning shares in quality businesses is hard to beat. Seemingly, though, I can’t help myself but try.